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Abstract Genetic variation among orthologous proteins can cause cryptic phenotypic properties
that only manifest in changing environments. Such variation may impact the evolvability of proteins,
but the underlying molecular basis remains unclear. Here, we performed comparative directed
evolution of four orthologous metallo-b-lactamases toward a new function and found that different
starting genotypes evolved to distinct evolutionary outcomes. Despite a low initial fitness, one
ortholog reached a significantly higher fitness plateau than its counterparts, via increasing catalytic
activity. By contrast, the ortholog with the highest initial activity evolved to a less-optimal and
phenotypically distinct outcome through changes in expression, oligomerization and activity. We
show how cryptic molecular properties and conformational variation of active site residues in the
initial genotypes cause epistasis, that could lead to distinct evolutionary outcomes. Our work
highlights the importance of understanding the molecular details that connect genetic variation to
protein function to improve the prediction of protein evolution.
DOI: https://doi.org/10.7554/eLife.40789.001
Introduction
Genetic diversity across orthologous proteins is thought to be predominantly neutral with respect to
their native, physiological function, but can cause variation in other non-physiological phenotypic
properties, a phenomenon known as ‘cryptic genetic variation’ (Le Rouzic and Carlborg, 2008;
Gibson and Dworkin, 2004; Paaby and Rockman, 2014). Cryptic genetic variation has been shown
to play an important role in evolution because genetically diverse populations are more likely to con-
tain genotypes with a ‘pre-adapted’ phenotype, for example, a latent promiscuous function, that
may confer an immediate selective advantage when the environment changes and a new selection
pressure emerges (Queitsch et al., 2002; Specchia et al., 2010; de Visser et al., 2011;
Amitai et al., 2007; Bloom et al., 2007; Rohner et al., 2013). Beyond that specific scenario, how-
ever, we have little understanding of how genetic variation affects the long-term adaptive evolution-
ary potential (or ‘evolvability’) of proteins (Wagner, 2008). Many biological traits, in particular
promiscuous protein functions, evolve by accumulating multiple adaptive mutations before reaching
a fitness plateau or peak. Thus, the degree to which a trait can improve and the level of fitness that
it can reach ultimately determines the evolutionary potential and outcome of a given genotype
(Romero and Arnold, 2009). Recent studies have shown that intramolecular epistasis is prevalent
and that the phenotypic effect of the same mutation can be drastically altered when introduced into
a genotype that differs by only a few other mutations, which may lead to different evolutionary out-
comes depending on the starting genotype (Blount et al., 2008; de Visser and Krug, 2014;
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Parera and Martinez, 2014; Starr and Thornton, 2016; Miton and Tokuriki, 2016; Harms and
Thornton, 2014; Starr et al., 2017). It has also been shown that orthologous enzymes can exhibit a
broad range of phenotypic responses to the same selection pressure to improve their promiscuous
activity (Khanal et al., 2015). These studies, however, have only focused on the effect of small muta-
tional steps; the degree to which genetic starting points determines long-term evolutionary out-
comes under identical selection remains unclear (O’Loughlin, 2006; Burch and Chao, 2000). More
importantly, our understanding of the molecular mechanisms that underlie the relationship between
genetic variation and evolvability is highly limited. It has been suggested that protein fold (To´th-
Petro´czy and Tawfik, 2014; Yip and Matsumura, 2013; Schulenburg et al., 2015) and protein sta-
bility (Weinreich and Chao, 2005; Bloom and Arnold, 2009; Tokuriki and Tawfik, 2009) can shape
evolvability, but these alone cannot explain the prevalence of epistasis and the enormous variation
we observe in the evolvability of different genotypes. An in-depth understanding of the molecular
constraints exerted by cryptic genetic variation is crucial to further develop our ability to decipher,
predict and design the evolution of proteins.
Metallo-b-lactamases (MBLs) encompass a genetically diverse enzyme family that confer b-lactam
antibiotic resistance to bacteria (Figure 1A,B) (Meini et al., 2014; Bebrone, 2007). Our previous
work demonstrated that most MBLs exhibit phosphonate monoester hydrolase (PMH) activity (kcat/
KM) in the range of 0.1 to 10 M
 1s 1 (Baier and Tokuriki, 2014; Baier et al., 2015). b-lactam and
phosphonate monoester hydrolyses differ in the cleaved bond (C-N vs. P-O) and the geometry of
the transition state (tetrahedral vs. trigonal bipyramidal), making the PMH activity a catalytically dis-
tinct promiscuous activity for these enzymes. Thus, the evolution of MBLs toward PMH activity can
be considered a model for neo-functionalization or the evolutionary emergence of a new enzyme
function. Here, we carried out an empirical test of enzyme evolvability by performing directed evolu-
tion with four orthologous MBLs (NDM1, VIM2, VIM7, and EBL1) toward PMH activity. Employing
diverse genetic, biochemical and biophysical analyses, we investigated the genetic and phenotypic
response of MBLs to a new selection pressure during laboratory evolution. Consequently, we
describe the molecular basis underlying these functional transitions: epistasis upon the fixation of a
key initial adaptive mutation appears to differentiate the evolutionary trajectories. Last, we discuss
the potential role of genetic variation in the evolution of new enzyme functions.
Results
Comparative directed evolution of four orthologous MBLs
We performed directed evolution using four different MBL orthologs, New Delhi metallo- b-lacta-
mase 1 (NDM1), Verona imipenemase 2 and 7 (VIM2 and VIM7), and Erythrobacter b-lactamase 1
(EBL1), as starting genotypes (Figure 1, Figure 1—figure supplement 1 and Supplementary file
1A). VIM2 and NDM1 were chosen due to the availability of their biochemical and structural informa-
tion (Garcia-Saez et al., 2008; King et al., 2012). VIM7 and EBL1 are close homologous enzymes to
VIM2 (80% amino acid sequence identity) and NDM1 (55% amino acid sequence identity), respec-
tively (Figure 1—figure supplement 1). Although the catalytic efficiencies for the native b-lactams
hydrolysis are similar across these enzymes (kcat/KM only varies up to twofold across all six MBLS),
their kcat/KM for the promiscuous PMH activity varies by ~20 fold (Figure 1A and
Supplementary file 1B). From these starting points, the same directed evolution scheme was
applied to improve their ability to hydrolyze PMH in Escherichia coli (Figure 1C). Briefly, randomly
mutagenized gene pools were transformed into E. coli, and purifying selection was used to enrich
for functional variants while purging out non-functional variants by plating the libraries onto agar
plates containing a low ampicillin concentration (4 mg/ml). Colonies were inoculated into liquid
media (96-well plates, total of 396 variants per round), regrown, lysed and screened for PMH activity.
The most improved variant(s) were isolated, sequenced and used as templates for the next round of
evolution. Note that the ‘PMH fitness’ (i.e. the selection criteria) in our directed evolution scheme is
defined as the level of PMH activity in E. coli cell lysate; as a result, PMH fitness is a function of cata-
lytic activity and soluble expression levels in the cell. For example, the PMH fitness differences
between NDM1 and VIM2 wild-type originate from their kinetic parameters, while their solubility is
comparable (Figure 1A,B). By contrast, EBL1 and VIM2 wild-type have similar catalytic efficiencies
Baier et al. eLife 2019;8:e40789. DOI: https://doi.org/10.7554/eLife.40789 2 of 20
Research article Biochemistry and Chemical Biology Evolutionary Biology
but their PMH fitness differ by 35-fold due to large differences in protein expression (Figure 1A and
Figure 1—figure supplement 1C).
Over the first two rounds of directed evolution (R2), we observed significant differences in the
extent of fitness improvement among the four parallel trajectories (Figure 1D). Interestingly,
improvements in PMH fitness did not correlate with the initial fitness level. For example, although
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Figure 1. Comparative directed evolution of metallo-b-lactamases (MBLs). (A) Catalytic efficiencies (kcat/KM) of six metallo-b-lactamases (MBLs) for b-
lactamase and PMH activities. Data are presented in Supplementary file 1B. The phylogenetic relationships are shown with bootstrap values indicated
at each node. (B) Comparison of the overall 3D structures and biophysical properties of NDM1 (blue, PDB ID: 3SPU) and VIM2 (green, PDB ID: 1KO3).
(C) Overview of the comparative directed evolution experiment of MBLs toward PMH activity. (D) PMH fitness (PMH activity in cell lysate) improvements
of four MBLS during directed evolution. Data are presented in Supplementary file 1G. (E) The mutations fixed in NDM1 and VIM2 over ten rounds of
directed evolution. The structural location of the mutations is mapped on the wild-type structures of NDM1 and VIM2, respectively, with the C-a atoms
of the mutated residues shown as spheres (upper panel). Mutations are presented on a partial alignment between NDM1 and VIM2 sequences (bottom
panel). A full alignment of MBLs and the mutations of the individual variants are presented in Figure 1—figure supplement 1 and Supplementary file
1F.
DOI: https://doi.org/10.7554/eLife.40789.002
The following figure supplement is available for figure 1:
Figure supplement 1. Sequence comparison between metallo-b-lactamases.
DOI: https://doi.org/10.7554/eLife.40789.003
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VIM2 is the variant with the highest initial activity, it only exhibited a 4-fold improvement in PMH fit-
ness over the wild-type, and was surpassed by other, initially less fit variants such as NDM1 and
EBL1, with a 210- and 310-fold improvement in PMH fitness, respectively. Overall, the close pairs of
homologues EBL1/NDM1 and VIM2/VIM7, seem to follow similar trends in PMH fitness improve-
ment. Consequently, we continued the directed evolution of VIM2 and NDM1 only, for eight addi-
tional rounds (Figure 1D and Supplementary file 1). Overall, both trajectories exhibited diminishing
returns in their evolution toward a new activity, that is each trajectory eventually reached a plateau
where no substantial fitness increase was obtained in the last rounds of directed evolution. Note
that in the last two rounds (R9 and R10), purifying selection was replaced by a pre-screening for
increased PMH fitness (PMH activity level in the cell) on agar plates (>5000 variants), yet no variant
with increased PMH fitness was isolated, suggesting that fitness plateaued in both trajectories
(Figure 1D). Besides the similar overall trend along the trajectories, there are substantial differences
in their evolutionary outcomes: while NDM1-WT was initially ~4 fold less-fit than VIM2-WT in PMH
fitness, NDM1 fitness became ~28 fold higher than that of VIM2 by the end of the evolutionary
experiment (R10). Overall, the NDM1 trajectory displays a ~ 3600 fold increase in PMH fitness
(between NDM1-R10 and NDM1-WT), whereas the VIM2 trajectory only exhibits a ~ 35 fold increase
in PMH fitness (Figure 1D and Supplementary file 1G), resulting in over a 100-fold difference in
PMH fitness improvement between the two trajectories. Given that the two wild-type enzymes were
almost identical in terms of their physicochemical properties, protein solubility, stability and structure
(Figure 1A,B), the variation in evolutionary potential that separates these orthologous sequences is
substantial.
Genotypic solutions vary across the evolutionary trajectories
Overall, NDM1 and VIM2 accumulated 13 and 15 mutations, respectively. Interestingly, the muta-
tions that occurred along each trajectory were entirely distinct (Figure 1E and Supplementary file
1F). Only two mutations occurred at the same position (154 and 223), and these were mutated to
different amino acids. For example, the mutations in the early rounds of evolution, which conferred
the largest PMH fitness improvements, were W93G, N116T, and K211R in the NDM1 trajectory, and
V72A, and F67L for VIM2. In NDM1, most mutations are scattered relatively evenly around the active
site; only one mutation (W93G) is located below loop 3, and several are located in and around loop
10 and other parts of the active site. By contrast, in VIM2, six mutations are tightly clustered within
or next to loop 3. These results demonstrate that, for these two enzymes, distinct fitness outcomes
result from distinct mutational responses.
A limited accessibility of adaptive mutations from each starting point
An important question arising from the observation that NDM1 and VIM2 responded differently to
the same selection pressure is whether their initial genotypes, and thus cryptic genetic variation,
determined their evolutionary PMH fitness outcome. To address this, one should ideally employ
experimental evolution using multiple parallel lineages and examine if evolution is repeatable from
each starting point. However, performing such high-throughput characterizations is not feasible
given our experimental evolution scheme. Nevertheless, we acquired several lines of evidence sug-
gesting that starting genotypes influence the PMH fitness outcomes observed during MBL evolution
(Figure 2).
First, we examined whether the adaptive mutations previously identified during directed evolu-
tion could be repeatedly selected by generating and screening three additional mutagenized librar-
ies from each wild-type enzyme (i.e. replaying R1 evolution). Strikingly, most positive variants
isolated in the additional screening possess mutations at the same positions as previously identified:
Trp93 (in R1) and Met154 (R5) were isolated for NDM1. For VIM2, Val72 (R1), Phe67 (R2), Ser202
(R4), Thr263 (R5), and Val41 (R6) were isolated again (Figure 2A, Figure 2—figure supplement 1
and Supplementary file 1H). These results suggest that only a handful of adaptive mutations, which
are unique to each genotype, are available, at least from the wild-type sequence.
Next, we assessed the PMH fitness effects of the NDM1 and VIM2 mutations by introducing the
mutations fixed during R2-R4 directly into their corresponding wild-type genetic background. In the
VIM2 trajectory, we observed no differential fitness effect when later mutations are directly intro-
duced on the wild-type background. This is consistent with the isolation of these later mutations
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during the additional R1 screening experiment, suggesting that a range of adaptive mutations is
readily accessible from the starting enzyme. As a consequence, these mutations can collectively
improve PMH fitness, regardless of their order of appearance and without significant epistatic con-
straint. On the contrary in NDM1, later mutations only confer a selective advantage if introduced
after the initial fixation of R1 mutations (Figure 2B). These results explain why only few mutations,
for example W93G, were identified in the additional screening from the starting enzyme. This also
suggests that W93G plays a permissive role for later mutations, and thus that the order of appear-
ance of mutations in the NDM1 trajectory is rather constrained.
Last, to examine why distinct mutations arise in the first round of the NDM1 and VIM2 trajecto-
ries, we examined the effect of the initial mutation from each trajectory (W93G in NDM1 and V72A
in VIM2) in their counterpart enzyme. We found that each trajectory’s adaptive mutations are incom-
patible with one another. While W93G increases PMH fitness in cell lysate by ~25 fold in NDM1-WT
(104-fold with purified NDM1), it causes a 3-fold decrease in PMH fitness when introduced into
VIM2-WT (10-fold with purified VIM2), explaining why VIM2 never acquired this mutation (Figure 2C,
E and Figure 2—figure supplement 2). W93G exhibits beneficial effects in MBL homologs other
than VIM2 and VIM1, consistent with the observation that Trp93 was not only selected in the NDM1
trajectory, but also in two other evolutionary trajectories, EBL1 and VIM7’s (W93L in EBL1 and
W93G in VIM7, respectively, Supplementary file 1F). Moreover, introducing other hydrophobic resi-
dues (A, V, L and F) at position 93 in VIM2 had similar negative effects, indicating that mutating
Trp93 is largely deleterious in VIM2 (Figure 2D). Similarly, V72A, which improved the PMH fitness of
VIM2 by ~2 fold (1.7-fold with purified enzyme), was largely neutral in NDM1 (Figure 2—figure sup-
plement 2 and Supplementary file 1I).
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Figure 2. Accessibility of adaptive mutations from each starting point. (A) Additional screenings of NDM1 and VIM2 round one libraries. Activities of
the top 30 variants isolated from additional screenings of three independently generated mutagenized libraries and normalized on the PMH fitness of
NDM1-WT and VIM2-WT, respectively; presented as scatterplots. Mutants are labeled when variants possess a mutation previously encountered in the
original directed evolution or if this mutation is located at the same position. Asterisks indicate that the variant has other mutations in addition to the
labeled one. Mutations and activities of all improved variants are listed in Supplementary file 1H. The activities of all 2160 variants in the round one
additional screenings are presented in Figure 2—figure supplement 1. (B) Epistasis analysis of mutations. Mutations occurring in the NDM1 and VIM2
trajectories were introduced into their respective wild-type sequence and the resulting PMH fitness was compared to the original PMH fitness change
observed during the trajectory. (C) Fold change in PMH fitness induced by mutation W93G in NDM1-WT and VIM2-WT, respectively. (D) Fold change in
PMH fitness induced by mutation of Trp93 in VIM2 to various hydrophobic residues. A full description of the lysate activities is presented in
Supplementary file 1G. Errors bars represent the propagated standard deviation from triplicate measurements.
DOI: https://doi.org/10.7554/eLife.40789.004
The following figure supplements are available for figure 2:
Figure supplement 1. Screening of additional libraries.
DOI: https://doi.org/10.7554/eLife.40789.005
Figure supplement 2. Differential effects of mutations (W93G and V72A) on six metallo-b-lactamases.
DOI: https://doi.org/10.7554/eLife.40789.006
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Distinct molecular changes underlie the two evolutionary trajectories
The conventional paradigm of protein evolution is dominated by the idea that higher protein stabil-
ity, or greater soluble and functional expression, promotes protein evolvability, by buffering the
destabilizing effect of function-altering mutations and allowing a greater number of adaptive muta-
tions to accumulate (Bloom and Arnold, 2009; Weinreich and Chao, 2005; Tokuriki and Tawfik,
2009). This model, however, fails to predict the difference in evolvability between NDM1 and VIM2,
because their relative stability and soluble expression are similar (Figure 1B). In order to elucidate
the precise molecular changes that enabled evolutionary optimization in each trajectory, we mea-
sured a range of molecular properties, including catalytic efficiency (kcat/KM), the fraction of soluble
protein expression, melting temperature (Tm), and oligomeric assembly, over the course of their evo-
lution. The molecular changes that underlie their respective PMH fitness (PMH activity in cell lysate)
improvements differed substantially (Figure 3, Figure 3—figure supplement 1 and
Supplementary file 2). By R10, the catalytic efficiency of NDM1 was improved by more than 18,000-
fold compared to the wild-type (kcat/KM from 0.32 to 5900 M
 1s 1, Figure 3A,B and
Supplementary file 2B). This significant improvement in catalytic efficiency, however, was offset by
a loss of soluble expression at R1, where kcat/KM increased by ~300 fold, while the solubility
decreased from 43% to 25% (Figure 3C,D). The level of soluble expression never recovered, while
kcat/KM gradually increased until reaching the plateau observed in R7. By contrast, the catalytic effi-
ciency of VIM2 stagnated at round 6, with only a ~ 25 fold increase in kcat/KM overall (VIM2-R10 com-
pared to the wild-type). The subsequent PMH fitness improvements resulted from increasing soluble
expression, from 40% to 70% (Figure 3). Changes in solubility are only weakly correlated to changes
in Tm (Figure 3—figure supplement 1), indicating that other factors such as kinetic stability or pro-
tein folding affect the level of soluble protein expression more than thermostability
(Bershtein et al., 2012; Wyganowski et al., 2013; Lim et al., 2016; Pey et al., 2011). NDM1
retains the same monomeric quaternary structure along its trajectory to NDM1-R10. The monomeric
VIM2-WT, however, evolved to exist in an equilibrium between monomer and dimer by VIM2-R10
(Figure 3—figure supplement 2A). We isolated monomeric and dimeric states, respectively, using
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Figure 3. Molecular and phenotypic changes along the NDM1 and VIM2 evolutionary trajectories. (A) Catalytic efficiencies (kcat/KM) of purified variants
for PMH activity. (B) Correlation between PMH fitness (cell lysate activity) and catalytic efficiency (kcat/KM in M
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DOI: https://doi.org/10.7554/eLife.40789.007
The following figure supplements are available for figure 3:
Figure supplement 1. Solubility and melting temperature of variants.
DOI: https://doi.org/10.7554/eLife.40789.008
Figure supplement 2. Oligomerization states of NDM1 and VIM2.
DOI: https://doi.org/10.7554/eLife.40789.009
Figure supplement 3. Effect of expression temperature on cell lysate PMH fitness (cell lysate activity in nM/s).
DOI: https://doi.org/10.7554/eLife.40789.010
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size-exclusion chromatography, and determined their kinetic parameters. The catalytic efficiency of
the dimeric state for PMH is eightfold lower compared to the monomeric state (kcat/KM = 510 and
60 M 1s 1 for the monomer vs. dimer, respectively), indicating that the dimer formation may be
associated with an overall increase in solubility, rather than catalytic efficiency along the VIM2 trajec-
tory (Figure 3—figure supplement 2) (Bershtein et al., 2012).
Altogether, our results suggest that two distinct molecular mechanisms underlie the observed dif-
ferences in evolutionary trajectories. NDM1 adapted exclusively by increasing catalytic efficiency
while compromising its soluble expression while VIM2 evolved by increasing its expression, oligo-
merization and activity. Our observations also indicate that differences in protein stability or soluble
expression in the initial genotypes cannot explain the differences in evolvability between the two
enzymes. VIM2 variants consistently exhibit higher stability and solubility throughout the trajectory,
yet the improvements in kcat/KM and PMH fitness are far lower than that of NDM1. Moreover, the
distinct phenotypic solutions further highlight the qualitatively different evolutionary processes that
led to distinct PMH fitness plateaus in each trajectory. Interestingly, the genetic differences in the
evolutionary end points can create additional cryptic variation that becomes apparent when the envi-
ronment is changed: when the enzymes are expressed at 37˚C (rather that 30˚C at which they
evolved for higher PMH fitness) NDM1 variants are significantly less fit because of their lower soluble
expression, whereas VIM2 variants maintain similar PMH fitness levels even at higher temperature
(Figure 3—figure supplement 3).
Distinct structural adaptation between the evolutionary trajectories
Having established that protein stability does not constrain the evolvability of the enzymes, we
sought a molecular explanation by solving the crystal structures of the R10 variants of the NDM1
and VIM2 trajectories, allowing us to compare them with the previously published wild-type struc-
tures (Figure 4 and Supplementary file 3) (King et al., 2012; Garcia-Saez et al., 2008). For NDM1-
R10, we obtained crystal structures of the apo-enzyme and in complex with the phenylphosphonate
product bound in the active site after in crystallo hydrolysis. Additionally, we conducted molecular
dynamics (MD) simulations in complex with the PMH substrate (p-nitrophenyl phenylphosphonate,
PPP). We identified three main structural adaptations from NDM1-WT that may underlie the ~18,000
fold improvement in catalytic efficiency for PMH activity. First, W93G removes steric hindrance
between the side chain of Trp93 and the substrate, and generates a complementary pocket for the
phenyl group below loop 3 (Figure 4B and Figure 5—figure supplement 1). Second, there is an
inward displacement of loop 3 (Trp93 is located near the base of this loop) by ~6 A˚, which allows for
improved p-p stacking interactions between Phe70 and the p-nitrophenol-leaving group (Figure 4C
and Figure 5—figure supplement 1). Third, loop 10 is repositioned via reorganization of the local
hydrogen bonding network (largely by K211R and G222D), allowing it to interact with the leaving
group of the substrate (Figure 4C). For VIM2, we were only able to crystallize the dimeric fraction of
VIM2-R10. This dimer reveals an unprecedented structural rearrangement: a full half of the structure
exhibits a symmetrical domain-swapping between the two subunits (Figure 4D and Figure 4—figure
supplement 1). Besides domain swapping, the major structural rearrangement occurring between
VIM2-WT and VIM2-R10 involves the reorganization of loop 3 resulting in its disorder in VIM2-R10,
which is most likely caused by six mutations within and next to loop 3 (Figures 1E and 4D). Four out
of these six loop 3 mutations have accumulated by R5; thus, we speculate that these mutations and
the loop rearrangement were the major cause of the ~25 fold increase in catalytic efficiency for PMH
in VIM2-R10, compared to the wildtype. Taken together, the results further emphasize that the two
starting enzymes responded to the same selection pressure by substantially different molecular
solutions.
Molecular basis for the mutational incompatibility of the key mutation
W93G
Finally, we investigated the molecular basis underlying the functional effect of W93G, a key mutation
that differentiates the two trajectories, by measuring the catalytic activities of the purified enzymes
at single enzyme and substrate concentrations. In NDM1, mutation W93G causes ~100 fold increase
in PMH activity compared to the wild-type, but when introduced into VIM2, it reduces its PMH activ-
ity by 10-fold (Figure 2—figure supplement 2 and Supplementary file 1I). We performed and
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compared MD simulations of NDM1-WT, VIM2-WT and models of NDM1-W93G, and VIM2-W93G in
the presence of the PMH substrate (Figure 5, Figure 5—figure supplement 2 and
Supplementary file 4). NDM1-W93G showed similar structural adaptations to NDM1-R10 (described
above); W93G eliminates the steric hindrance with the substrate, and allows loop 3 to shift inward to
promote complementary interactions with the substrate, without the rearrangement of loop 10,
which presumably occurs later in evolution. By contrast, in VIM2-WT, Trp93 adopts a different orien-
tation to avoid steric hindrance, which instead promotes complementary interactions with the phenyl
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Figure 4. The structural basis for improved PMH activity. (A) Structural overlay of NDM1-WT (grey, PDB ID: 3SPU) and NDM1-R10 in the apo form (cyan,
PDB ID: 5JQJ) and NDM1-R10 in complex with the PMH hydrolysis product, phenylphosphonate (PhPn, magenta sticks) (blue, PDB ID: 5K4M). The
active site metal ions are shown as spheres. (B) Surface views of the active site of NDM1-WT and NDM1-R10 with the PMH product. The product in the
NDM1-WT structure is overlaid from the NDM1-R10 structure. The mFo-dFc omit electron density for the phenylphosphonate is shown (green mesh),
contoured at 2.5s. (C) Comparison of active site residues between NDM1-WT and NDM1-R10. (D) Structural overlay of monomeric VIM2-WT (grey, PDB
ID: 1KO3) and domain swapped-dimeric VIM2-R10 (green and pink, PDB-ID: 6BM9). The disordered loop three in VIM-R10 is indicated as a dashed
green line. The mutations accumulated during the VIM2 trajectory are depicted as light grey spheres. The mFo-Fc omit electron density of the structure
can be found in Figure 4—figure supplement 1.
DOI: https://doi.org/10.7554/eLife.40789.011
The following figure supplement is available for figure 4:
Figure supplement 1. Structure of the domain swapped-dimeric VIM2-R10.
DOI: https://doi.org/10.7554/eLife.40789.012
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ring of the substrate. Consequently, W93G in VIM2 removes beneficial substrate-enzyme interac-
tions, thus causing a deleterious effect on catalytic efficiency. Similarly, unlike in NDM1, loop 3 in
VIM2-W93G does not form complementary interactions with the substrate, which is consistent with
the observation that loop 3 is extensively mutated and reorganized by other mutations later in the
VIM2 trajectory. By examining these crystal structures, we found that the ‘second-shell’ residues of
Trp93 cause its indole side chain to adopt a different orientation. In NDM1, Leu65, Gln123 and
Asp124 constrain Trp93 to point toward the active site (Figure 5D). In VIM2, however, the second
shell residues (Gln65, Asp123, and Asp124) differ, resulting in Trp93 being stabilized in an alterna-
tive conformation (Figure 5E). Thus, remote and seemingly neutral sequence variation between the
enzymes has substantial impact on the mutagenesis of a key active site residue.
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Figure 5. Comparisons of the structural changes induced by mutation W93G. Representative structures from MD simulations of (A) NDM1-WT (grey)
and NDM1-W93G (blue), and (B) VIM2-WT (grey) and VIM2-W93G (green). (C) Changes in hydrophobic interactions between the phenyl ring of the PMH
substrate (CE3 and CZ2 atoms) and residue Leu65 and Val73 (a-carbon) of NDM1 upon W93G, during the MD simulations. (D and E) Comparison of the
position of Trp93 and second shell residues in the (D) NDM1-WT (PDB-ID: 3SPU) and (E) VIM2-WT (PDB-ID: 1KO3) crystal structures. (F) Average
distance between the p-nitrophenyl ring of the PMH substrate and the side chain rings of Phe70 in NDM1, and Tyr73 in VIM2, when the two rings form
a p-p interaction during the MD simulations.
DOI: https://doi.org/10.7554/eLife.40789.013
The following figure supplements are available for figure 5:
Figure supplement 1. The molecular dynamics (MD) simulations of NDM1-WT and NDM1-R10.
DOI: https://doi.org/10.7554/eLife.40789.014
Figure supplement 2. The molecular dynamics (MD) simulations of NDM1-WT, NDM1-W93G, VIM2-WT, and VIM2-W93G.
DOI: https://doi.org/10.7554/eLife.40789.015
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We expanded our mutational analysis of W93G and V72A (the first mutation in the VIM2 trajec-
tory) by measuring their effects on four other orthologous enzymes: EBL1, Florence Imipenemase 1
(FIM1), VIM1, and VIM7; with purified enzymes at single substrate and enzymes concentrations. We
found that their effects on both PMH and b-lactamase activities vary consistently and significantly,
even between orthologs with high sequence identity (Figure 2—figure supplement 2 and
Supplementary file 1I). For example, in VIM7, which is 80% identical to VIM2, W93G caused a ~ 3
fold increase in PMH activity, despite the same mutation causing an antagonistic 10-fold decrease in
PMH activity in VIM2. Taken together, cryptic and subtle differences in sequence and structure in
both orthologs may influence the conformation of Trp93, a key active site residue, and cause the
observed 1000-fold difference in the phenotypic effect of mutation W93G (100-fold increase in
NDM1 vs. 10-fold decrease in VIM2). Thus, as previously discussed, the accessibility of adaptive
mutations from each starting point, at least within one mutational step, seems to depend on the
starting genotype (Figure 2).
Discussion
The existence of a great diversity of protein functions, together with many contemporary examples
of proteins that have promptly adapted to changing environments, suggest a remarkable degree of
evolvability for biological molecules (Wagner, 2008; Aharoni et al., 2005; Baier et al., 2016). These
successful examples of adaptation, however, may also obscure a wealth of cases where proteins
have failed to adapt or were limited in their ability to evolve a new function. Our observations high-
light that not all enzymes evolve to their fitness maximum, and that seemingly innocuous genetic var-
iation may result in significant consequences for a protein’s ability to evolve a new function. Metallo-
b-lactamases (MBLs) confer b-lactam antibiotic resistance to bacteria by cleaving b-lactam rings (C-N
bond). The PMH activity (breaking P-O bond) in MBLs is not likely to have ever been selected for; it
can thus be considered as a truly non-physiological and serendipitous promiscuous function
(Khersonsky and Tawfik, 2010; Babtie et al., 2010; Copley, 2015). Thus, the promiscuous PMH
activity of MBLs can be considered a cryptic and hidden ‘pre-adapted’ property. Genetic variation
can alter the level of promiscuous activities in enzymes (de Visser et al., 2011; Bloom et al., 2007;
Amitai et al., 2007). Indeed, in MBLs, the catalytic efficiencies for PMH hydrolysis differ by ~20 fold
among orthologous enzymes, while the catalytic efficiencies for b-lactams hydrolysis only vary by
twofold (Figure 1A). Such phenotypic variation can cause differences in evolvability when an ‘imme-
diate’ response to changing environments is essential (de Visser et al., 2011; Bloom et al., 2007;
Amitai et al., 2007). Our work extends this view of the role of genetic diversity to encompass the
evolutionary responses of individual genes to new selection pressures (Khanal et al., 2015). Impor-
tantly, the initial fitness and/or the catalytic efficiencies of enzymes do not necessarily provide a
good indicator of their evolutionary outcome, and thus of their evolvability (Khanal et al., 2015).
Genetic variation can significantly alter the accessibility of adaptive mutations, and starting points
with lower fitness may reach much higher evolutionary plateaus than starting points endowed with
higher initial fitness. Thus, adaptive evolutionary potential can be truly ‘cryptic’ and only apparent
after evolution happens, further complicating the prediction of the most successful initial genotypes.
Our observations, when combined with those of others, indicate that the evolvability of proteins
is generally and profoundly rooted in the starting genetic variation that is available. On one hand,
examples from nature and the laboratory have shown that independent evolutionary trials from a sin-
gle genotype often follow very similar genetic and thus phenotypic trajectories; suggesting that only
a limited amount of beneficial mutations is available from any single genotypic starting point, and in
those cases evolution is largely deterministic (Weinreich et al., 2006; Salverda et al., 2011;
Lobkovsky and Koonin, 2012; Dickinson et al., 2013; Palmer et al., 2015; Kaltenbach et al.,
2015). On the other hand, the prevalence of epistasis causes distinct effects when some adaptive
mutation(s) are introduced on the genetic background of otherwise phenotypically similar orthologs
(Khanal et al., 2015; Parera and Martinez, 2014; Harms and Thornton, 2014; Starr et al., 2017),
suggesting that genetic variation epistatically ‘restricts’ and/or ‘permits’ the accessibility of certain
adaptive mutations (Harms and Thornton, 2013; Kaltenbach and Tokuriki, 2014; Starr and Thorn-
ton, 2016). The successful evolution of new protein functions may therefore rely on genetic drift to
explore the sequence space, thereby creating a diverse genotypic pool presenting multiple, differen-
tially evolvable, genotypes from which an evolutionary trajectory may arise (Harms and Thornton,
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2014). The genetic diversity that these neutral drifts generate thereby provides a foundation for the
response of a population to new selection pressures (Wagner, 2008; Harms and Thornton, 2013).
One complicating aspect of this model is the impact of temporal and spatial selection on the emer-
gence of diverse genotypes. It is possible that this model explains a commonly observed phenome-
non in bacterial adaptation, for example, drug-resistance and xenobiotic degradation
(Copley, 2009; Singh, 2009), in which typically only a small number of genotypes endowed with
new functions will emerge within a larger population, after which these successfully adapted genes
quickly disseminate to other bacteria via horizontal gene transfer.
Our observations shed light on the molecular mechanisms underlying genetic variation and evolu-
tion of new enzymatic function. The established and conventional paradigm of protein evolution sug-
gests that protein stability, or soluble and functional expression of proteins, is the dominant factor in
determining evolvability (Bloom and Arnold, 2009; Tokuriki and Tawfik, 2009; Weinreich and
Chao, 2005). Other studies indicate that protein structural folds cause differences in evolvability
(Yip and Matsumura, 2013; Schulenburg et al., 2015; Dellus-Gur et al., 2013; To´th-Petro´czy and
Tawfik, 2014). However, in our study, neither protein stability nor protein fold can account for varia-
tion in evolutionary potential between the MBL enzymes toward PMH activity. Instead, we found
that cryptic and subtle molecular differences seem to have a greater impact on granting the accessi-
bility of key initial adaptive mutations (such as W93G): although VIM2 and NDM1 possess an almost
identical overall structure, thermostability and soluble expression level, their evolution resulted in
substantially different fitness outcomes and molecular solutions. Indeed, many examples demon-
strated that strong epistasis in protein function can be caused by subtle conformational changes
through the accumulation of mutations (Tomatis et al., 2008; Harms and Thornton, 2014; Dellus-
Gur et al., 2015; Yang et al., 2016; Campbell et al., 2016). Thus, an in-depth understanding of the
molecular and evolutionary mechanisms underlying the optimization of enzymatic functions, in par-
ticular of promiscuous activities, is essential to developing our ability to understand and predict the
evolution of enzymes.
These results also have implications for protein engineering, laboratory evolution and protein
design. Protein engineers often choose a single starting genotype based on the availability of bio-
chemical and structural information (often orthologs with the highest initial activity). While much
effort has been devoted to developing technologies for better library construction and high-
throughput screening (Dalby, 2011; Davids et al., 2013; Goldsmith et al., 2017), our observations
suggest that it may also be effective to explore diverse initial genotypes and identify the most evolv-
able starting sequences to successfully obtain an optimized functional protein (Lapidoth et al.,
2018; Kiss et al., 2013). Yet, predicting the evolvability of proteins remains a challenge that will
require more in-depth biochemical and biophysical characterizations in order to dissect the molecu-
lar mechanisms driving the evolution of protein function (Miton et al., 2018; Clifton et al., 2018;
Kaltenbach et al., 2018). The biophysical rationalization of the cryptic properties of MBL enzymes
described here contributes to the ambitious goal of understanding the molecular mechanisms
behind neutral genetic variation and evolvability that we observe in nature, in such a way as to allow
us to predict evolutionary pathways and understand how to acquire better biological molecules.
Materials and methods
Generation of mutagenized library
Random mutant libraries were generated with error-prone PCR using nucleotide analogues (8-Oxo-
2’-deoxyguanosine-5’-Triphosphate (8-oxo-dGTP) and 2’-Deoxy-P-nucleoside-5’-Triphosphate
(dPTP); TriLink). Two independent PCR reactions were prepared, one with 8-oxo-dGTP and one with
dPTP. Each 50 ml reaction contained 1  GoTaq Buffer (Promega), 3 mM MgCl2, 1 ng template DNA,
1 mM of primers (forward (T7 promoter): taatacgactcactataggg; reverse (T7 terminator): gctagt-
tattgctcagcgg), 0.25 mM dNTPs, 1.25 U GoTaq DNA polymerase (Promega) and either 100 mM 8-
oxo-dGTP or 1 mM dPTP. Cycling conditions: Initial denaturation at 95˚C for 2 min followed by 20
cycles of denaturation (30 s, 95˚C), annealing (60 s, 58˚C) and extension (70 s, 72˚C) and a final
extension step at 72˚C for 5 min. Subsequently, each PCR was treated with Dpn I (Fermentas) for 1
hr at 37˚C to digest the template DNA. PCR products were purified using the Cycle Pure PCR purifi-
cation kit (E.N.Z.A) and further amplified with a 2  Master mix of Econo TAQ DNA polymerase
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(Lucigen) using 10 ng of the template from each initial PCR and the same primers at 1 mM in a 50 ml
reaction volume. Cycling conditions: Initial denaturation at 95˚C for 2 min followed by 30 cycles of
denaturation (30 s, 95˚C), annealing (20 s, 58˚C) and extension (70 s, 72˚C) and a final extension step
at 72˚C for 2 min. The PCR products were purified and cloned as described above. Sequencing of
naı¨ve libraries for NDM1 and VIM2 revealed differences in mutation rates between the two genes.
The variants exhibited on average 2.6 mutations/gene for NDM1 and 4.3 mutations/gene for VIM2
(Supplementary file 1C). Since the two genes were mutated under identical conditions, this is likely
due to intrinsic sequence properties of the templates, in terms of DNA composition for example.
Generation of DNA shuffling libraries
The staggered extension process (StEP) protocol is a DNA shuffling method that was used at rounds
where multiple variants exhibited higher PMH fitness (rounds 2 and 5 in NDM1; 4 and 10 in VIM2), in
order to enrich beneficial mutations and purge deleterious or neutral ones (Supplementary file 1F)
(Zhao et al., 1998). Plasmids of variants were mixed in equimolar amounts to 500 ng of total DNA
and used as a template for the StEP reaction. Cycling conditions: Initial denaturation at 95˚C for 5
min followed by 100 cycles 95˚C for 30 s followed by 58˚C for 5 s. PCR products were purified using
the Cycle Pure PCR purification kit and further amplified with a 2  Master mix of Econo TAQ DNA
polymerase. Libraries were cloned into pET29(b) as described above.
Site-directed mutagenesis
Single-point mutant variants were constructed by site-directed mutagenesis as described in the
QuickChange Site-Directed Mutagenesis manual (Agilent) using specific primers. All variants con-
tained only the desired mutation, which was confirmed by DNA sequencing.
Pre-screen on agar plates
Libraries in pET29-pMBP were transformed into E. coli BL21 (DE3) cells and incubated for 1 hr at
37˚C prior to plating. For the low antibiotic prescreen, the transformants were plated on agar plates
(150 mm diameter) containing 4 mg/ml ampicillin, 0.1 mM IPTG, 200 mM ZnCl2 and 40 mg/ml kanamy-
cin, yielding >500 colonies. The minimum inhibitory concentration (MIC) of ampicillin for E.coli cells
expressing NDM1 and VIM2 is 256 mg/ml, whereas for the E.coli cells alone it is <2 mg/ml. Subse-
quently, surviving colonies were directly picked from plates for rescreening in 96-well plates. For the
direct PMH prescreen, transformation reactions were plated on six agar plates (150 mm diameter)
containing 40 mg/ml kanamycin, such that each plate contained between 400 and 2000 colonies. Col-
onies were replicated onto nitrocellulose membranes (BioTrace NT Pure Nitrocellulose Transfer
Membrane 0.2 mm, PALL Life Sciences), which were subsequently placed onto LB agar plates con-
taining 1 mM IPTG, 200 mM ZnCl2 and 40 mg/ml kanamycin for overnight protein expression at room
temperature. After expression, membranes were transferred to empty petri dishes and the cells
were lysed by freeze-thaw cycles (three times,  20 and 37˚C, 10 min). To assay activity, 25 ml of
0.5% Agarose in 50 mM Tris-HCl buffer pH 7.5 containing 200 mM ZnCl2 and 250 mM p-nitrophenyl
phenylphosphonate (Sigma) was poured onto the membrane. Colonies with active enzymes devel-
oped a yellow colour due to the hydrolyzed substrate. The most active colonies (~200 variants) were
directly picked from plates for rescreening in 96-well plates.
Cell lysate activity screen in 96-well plates
To test the PMH fitness and solubility of the variants, individual wells of a 96-well plate containing
400 ml of LB media supplemented with 40 mg/ml kanamycin were inoculated with 20 ml of overnight
culture and incubated at 30˚C for 3 hr. Protein expression was induced by adding IPTG to a final
concentration of 1 mM and further incubation at 30˚C (20˚C and 37˚C for testing temperature effect
on expression) for 3 hr. Cells were harvested by centrifugation at 4000  g for 10 min and pellets
were frozen at  80˚C for at least 30 min. For lysis, cell pellets were resuspended in 200 ml of lysis
buffer (50 mM Tris-HCl pH 7.5, 100 mM NaCl, 200 mM ZnCl2, containing 0.1% Triton X-100, 100 mg/
ml lysozyme and 1 U/ml of benzonase) and incubated at 25˚C with shaking at 1200 rpm for 1 hr. The
cell lysates were clarified by centrifugation at 4000  g for 20 min at 4˚C. Clarified lysates were
diluted twofold for phosphonate hydrolase activity prior activity assays in order to obtain linear initial
rates, which were measured at a single substrate concentration of 500 mM. ‘PMH fitness’ is defined
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as the rate of product formation (nM/s) measured in cell lysate using an extinction coefficient of
18,300 M 1 cm 1 (for the p-nitrophenol product) and correcting for lysate dilution (i.e.  2 fold in
this case).
Purification of Strep-tagged proteins
All variants were cloned as described above, transformed, overexpressed in E. coli BL21 (DE3) cells
and purified as described previously (Baier and Tokuriki, 2014).
Enzyme kinetics
The kinetic parameters and activity levels of purified of enzyme variants were obtained as described
previously (Baier and Tokuriki, 2014). Briefly, phosphonate monoester hydrolase (PMH) hydrolysis
was monitored following the release of p-nitrophenol at 405 nm with an extinction coefficient of
18,300 M 1 cm 1. The b-lactamase activity was monitored at 405 nm using Centa as substrate, and
molar product formation was calculated with the extinction coefficient of 6300 M 1 cm 1.
Thermostability assay
The thermal stability of variants was measured with a thermal shift assay as described previously
(Wyganowski et al., 2013). Briefly, enzyme variants (2 mM) were mixed with 5  SYPRO Orange dye
(Invitrogen) in a 20 ml reaction and heated from 25˚C to 95˚C in a 7500 Fast Real-Time PCR system
(Applied Biosystems). Measurements were conducted in triplicate and unfolding was followed by
measuring the change in fluorescence caused by binding of the dye (excitation, 488 nm; emission,
500–750 nm). The melting temperature (Tm) is calculated from midpoint of the denaturation curve
and values were averaged.
Protein purification for crystallization
The NDM1 and VIM2 protein variants were expressed in E. coli BL21 (DE3) cells in TB medium (400
ml) supplemented with 1% glycerol, 50 mg/ml kanamycin and 200 mM ZnCl2. Cells were grown at
30˚C for 6 hr. The temperature was lowered to 22˚C and the cells were incubated for a further 16 hr
and harvested by centrifugation for 15 min at 8500  g (R9A rotor, Hitachi), then resuspended in
buffer A (50 mM HEPES pH 7.5, 500 mM NaCl, 20 mM imidazole, and 200 mM ZnCl2) and lysed by
sonication (OMNI sonic ruptor 400). Cellular debris was removed by centrifugation at 29,070  g for
60 min (R15A rotor, Hitachi). The supernatant was loaded onto a 5 ml Ni-NTA superflow cartridge
(Qiagen) followed by extensive washing with buffer A prior to elution of proteins in buffer B (50 mM
HEPES pH 7.5, 500 mM NaCl, 500 mM imidazole, and 200 mM ZnCl2). Protein containing fractions
were analyzed by SDS-PAGE (Bolt Mini Gels, Novex). Buffer B containing the proteins was
exchanged to TEV reaction buffer (50 mM Tris-HCl pH 8.0, 0.5 mM EDTA, 1 mM DTT, and 150 mM
NaCl) using HiPrep 26/10 desalting column (GE healthcare). 20% TEV (w/w) was added and incu-
bated at 4˚C for 4 days. The TEV reaction buffer was exchanged to buffer A before TEV protease
and His-tag containing debris were removed by Ni-NTA superflow column (5 ml, Qiagen). His-tag
cleaved protein was then concentrated using a10 kDa molecular weight cut-off MWCO ultrafiltration
membrane (Amicon, Millipore) and loaded on HiLoad 16/600 Superdex 75 pg column (GE Health-
care). Proteins were eluted into crystallization buffers.
Crystallization of NDM1-R10
NDM1-R10 protein in crystallization buffer (20 mM HEPES pH 7.5, 2 mM b-mercaptoethanol, 150
mM NaCl, and 100 mM ZnCl2) was concentrated to 15 mg/ml using a 10 kDa molecular weight cut-
off ultrafiltration membrane (Amicon, Millipore) and crystallized by the hanging drop method. The
hanging drops were prepared by mixing protein solution (1 ml) and well solution (2 ml). Crystals
appeared within two weeks in 0.1 M MES (pH 6.75) and 1.3 M MgSO4 at 18˚C and continued to
grow. Crystals were soaked in a cryoprotectant solution for 30 s (precipitant, and 25% glycerol), and
flash cooled in liquid nitrogen. The apo (without substrate) enzyme crystal diffracted to 1.67 A˚ at
beam line MX1 at the Australian Synchrotron. The product-bound structure was obtained by soaking
the crystal in precipitant solution, containing 15 mM substrate for 3-to-30 minutes before soaking in
cryoprotectant solution and flash cooling in liquid nitrogen. The crystals diffracted to 1.68–2 A˚ at
beam line MX2 (0.9537 A˚) at the Australian Synchrotron.
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Crystallization of VIM2-R10
The first size exclusion peak of VIM2-R10 protein (dimeric fractions), in buffer containing 50 mM
HEPES pH 7.5, 150 mM NaCl, and 200 mM ZnCl2, was concentrated to 2.6 mg/ml using a 10 kDa
molecular weight cut-off ultrafiltration membrane (Amicon, Millipore) and crystallized by the hanging
drop method. The drops were prepared by mixing a protein solution (2 ml), well solution (4 ml), 1 mM
TCEP, and 2.5 mM p-nitrophenyl phenylphosphonate. Crystals appeared after two weeks in 0.1 M
HEPES (pH 7.5) and 1.2 M sodium citrate at 18˚C. Crystals were soaked in cryo-protectant solution
for several minutes (precipitant, and 10% glycerol), and flash cooled in liquid nitrogen. The crystal
diffracted to 2 A˚ at beam line MX1 (0.9537 A˚) at the Australian Synchrotron.
Data collection and structure determination
The crystallographic data were collected at 100 K at the Australian Synchrotron. Data were proc-
essed using XDS (Kabsch, 2010). Scaling was performed using Aimless in the CCP4 program suite.
Resolution estimation and data truncation were performed by using overall half-dataset correlation
CC(1/2)>0.5 (Karplus and Diederichs, 2012). Molecular replacement was used to solve all structures
with MOLREP (Vagin and Teplyakov, 2010) using the structures deposited under PDB accession
codes 3SPU and 1KO3 as starting models for NDM1 and VIM2, respectively. The model was refined
using phenix.refine (Afonine et al., 2012) and Refmac v5.7 (Murshudov et al., 2011) in CCP4 v6.3
program (Winn et al., 2011), and the model was subsequently optimized by iterative model building
with the program COOT v0.7 (Emsley and Cowtan, 2004). The structure of VIM2-R10 in its apo
form (without substrate) (PDB-ID: 6BM9), and of NDM1-R10 in its apo form (PDB ID: 5JQJ) or in
complex with the phenylphosphonic acid product (pdb ID: 5K4M) have been deposited in the RCSB
Protein Data Bank, www.rcsb.org. For a complete description of the crystallographic data collection
and refinement statistics, see Supplementary file 3.
Molecular dynamics simulation
Molecular dynamics simulations VIM2 and NDM1 variants were performed using the Q simulation
package (Marelius et al., 1998) and the OPLS-AA force field (Jorgensen et al., 1996). OPLS-AA
compatible parameters for p-nitrophenyl phenylphosphonate (PMH substrate, PPP) were generated
using MacroModel version 10.3 (Schro¨dinger LLC, v. 2014–1). Partial charges for PPP were calcu-
lated using the standard RESP procedure (Cieplak et al., 1995), with the use of Antechamber
(AmberTools 12) (Wang et al., 2006) and Gaussian09 (Revision C.01) (Frisch et al., 2016). All other
PPP parameters were as presented in the supporting information of Ref. (Barrozo et al., 2015). The
structures of VIM2-WT (Chain B, PDB ID 4PVO) and NDM1-WT (PDB ID 4HL2) were obtained from
the Protein Data Bank. These structures were used for MD calculations because of their high-resolu-
tion, whereas 3SPU and 1KO3 were used for structural analysis due to the absence of ligand in the
active site. The structure of NDM1-R10 with the PMH product, phenylphosphonic acid bound (PDB
ID 5K4M) was obtained as described in the previous section. The structures of single W93G mutants
for both VIM2 and NDM1 were manually generated by mutating the respective tryptophan residues
to glycine in the wild-type structures prior MD simulation. The PMH substrate was manually placed
in the active site of the respective enzymes, based on the position of the phenylphosphonic acid
product in the NDM1-R10 crystal structure. The Zn2+ ions were described using a tetrahedral dummy
model based on the dummy model originally described by Aqvist and Warshel (1989). The model
was built by placing four dummy atoms in a tetrahedral geometry around a central metal particle,
and parametrised to reproduce the experimental solvation free energy and solvation geometry of
the zinc ion (for the description of analogous octahedral dummy model and parameterization proce-
dure see Ref. (Duarte et al., 2014)). The resulting Zn2+ parameters used in this work are presented
in Supplementary file 4A. All simulations were performed using surface-constrained all-atom solvent
(SCAAS) boundary conditions (King and Warshel, 1989) applied to a spherical droplet of TIP3P
water molecules (Jorgensen et al., 1983) with a radius of 24 A˚ centered on the bridging hydroxide
ion. All protein atoms and water molecules within 85% of the solvent sphere were allowed to move
freely with no restraints, atoms in the last 15% of the sphere were subject to 10 kcal mol 1 A˚ 2 posi-
tional restraints, and all atoms outside this sphere were subjected to 200 kcal mol 1 A˚ 2 positional
restraints to maintain them at their crystallographic positions. Protonation states of all ionisable resi-
dues within the inner 85% of the simulation sphere were assigned using PROPKA 3.1
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(Søndergaard et al., 2011; Olsson et al., 2011) and the protonation states of histidine side chains
were determined by visual inspection of the surrounding hydrogen bonding pattern of each residue.
The relevant protonation states and histidine protonation parameters are presented in
Supplementary file 4B. All ionizable residues outside of the 85% of the sphere were kept in their
uncharged forms to avoid simulation artefacts caused by having charged residues in the excluded
region of the simulations. All systems were initially equilibrated with 200 kcal mol 1 A˚ 2 positional
restraints over the total timescale of 95 ps, during which the alternating heating, cooling and reheat-
ing was performed to release steric clashes and equilibrate the positions of the solvent molecules
and hydrogen atoms, and to reach the target simulation temperature of 300K. The initial equilibra-
tion was completed by performing 10 ns of simulation at 300K, which was followed by 100 ns pro-
duction simulation, the last 50 ns of which was subject to further analysis. This protocol was
repeated five times generating five independent 100ns trajectories for each system. The root mean
square deviations of all C-a atoms in our simulations is shown in Figure 5—figure supplement 2,
which demonstrates that all simulations have equilibrated during the 100 ns simulation time. During
the final stage of the equilibration and production simulations weak 0.5 kcal mol 1 A˚ 2 restraints
were applied on the PMH substrate in order to keep it within the simulation sphere, and 1.0 kcal
mol 1 A˚ 2 restraints were applied on the metal ions, side chains of the metal ligands and the bridg-
ing hydroxide ion to assure proper coordination geometry of the metal centers. Apart from the very
initial stages of the equilibration where a 0.01 and 0.1 fs time step was used, a 1 fs time step was
used throughout the simulations. The results of the simulations were analyzed using: VMD
(Humphrey et al., 1996), and GROMACS (Abraham et al., 2015). The raw data of the MD simula-
tions are available from the Dryad Digital Repository at doi:10.5061/dryad.qk653b3.
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